SAFC showcases HPAPI handling capabilities

By Gareth Macdonald

30-Oct-2008 - Last updated on 28-Sep-2021 at 11:50 GMT

SAFC's Mike Harris sets out the firm's role in the expanding high-potency active pharmaceutical ingredient (HPAPI) industry.

SAFC's Mike Harris sets out the firm's role in the expanding high-potency active pharmaceutical ingredient (HPAPI) industry.

Related news

Follow us

Products

View more

Powered by Ingredients + Innovation Univar Solutions USA | Download Product Brochure
Solution for challenging antibodies – Planova™ S20N Asahi Kasei Medical Co., Ltd. | Download White Paper
Accurate determination of resin substitution in solid phase peptide synthesis Almac Group | Download White Paper

Webinars

On-demand webinars

Manufacturing Friendly Aggregate Clearance in Downstream Processing of Bispecific and Traditional Antibodies Using a Novel POROS Thermo Fisher Scientific – Production Chemicals and Services

Headlines